Sunflower Pharmaceutical Group Co., Ltd. (SHE:002737)
China flag China · Delayed Price · Currency is CNY
11.59
-0.11 (-0.94%)
Sep 10, 2026, 1:45 PM CST

SHE:002737 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,395852.821,0402,2872,3991,320
Short-Term Investments
-----304.42
Trading Asset Securities
1,2821,7551,2581,3151,449668.69
Cash & Short-Term Investments
2,6772,6082,2983,6023,8472,293
Cash Growth
1.32%13.47%-36.19%-6.38%67.77%27.52%
Accounts Receivable
140.23182.31584.93110.13184.25268.98
Other Receivables
11.268.8214.9541.4242.5712.21
Receivables
151.49191.13599.88151.56226.82281.19
Inventory
631.68617.43867.31873.19632.08709.64
Prepaid Expenses
-11.5431.6844.33.748.75
Other Current Assets
87.5373.6188.23116.81151.03100.11
Total Current Assets
3,5473,5023,8864,7884,8613,393
Property, Plant & Equipment
1,1441,2081,3111,4351,4971,577
Long-Term Investments
74.5394.8897.12122.44141.38131.32
Goodwill
56.4456.4486.9891.7791.77107.6
Other Intangible Assets
301.09312.73332.64345.37366.52337.77
Long-Term Deferred Tax Assets
63.4964.1537.6258.9256.5155.78
Long-Term Deferred Charges
4.516.7510.038.866.811.87
Other Long-Term Assets
112.8183.964.8931.3910.8530.77
Total Assets
5,3045,3285,8266,8827,0325,635

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
387.89421.62319.05734.6714.48547.18
Accrued Expenses
45.22136.84205.55233.76301.01124.75
Short-Term Debt
156.16108.490.0214.43420200
Current Portion of Leases
-4.444.954.465.593.5
Current Income Taxes Payable
45.655.964.7387.5360.2143.54
Current Unearned Revenue
178.41272.57285.68297.32551.54167.04
Other Current Liabilities
204.47201.6207.55147.8122.54166.6
Total Current Liabilities
1,0221,1521,0281,5202,1751,253
Long-Term Debt
30----33.57
Long-Term Leases
1.5334.037.6210.57.01
Long-Term Unearned Revenue
171.73178.83199.37342.08397.26389.08
Long-Term Deferred Tax Liabilities
2.213.014.957.619.8917.82
Other Long-Term Liabilities
1.31.3----
Total Liabilities
1,2281,3381,2361,8772,5931,700

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
584584584584584584
Additional Paid-In Capital
929.06929.06918.43915.66889.99896.7
Retained Earnings
2,3982,3182,8683,2522,7162,256
Treasury Stock
------44
Comprehensive Income & Other
6.616.99.1612.2814.3816.77
Total Common Equity
3,9173,8384,3794,7634,2053,709
Minority Interest
158.36152.37210.86241.25234225.72
Shareholders' Equity
4,0763,9914,5905,0054,4393,935
Total Liabilities & Equity
5,3045,3285,8266,8827,0325,635

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
191.62115.938.9926.52436.08244.08
Net Cash (Debt)
2,4852,4922,2893,5763,4112,049
Net Cash Growth
-5.76%8.85%-35.97%4.82%66.47%37.72%
Net Cash Per Share
4.294.253.916.135.823.52
Filing Date Shares Outstanding
554.83584584584584587.54
Total Common Shares Outstanding
554.83584584584584587.54
Working Capital
2,5252,3502,8583,2682,6862,140
Book Value Per Share
7.066.577.508.167.206.31
Tangible Book Value
3,5603,4693,9604,3263,7463,264
Tangible Book Value Per Share
6.425.946.787.416.425.56
Buildings
-1,5651,5671,6121,6041,589
Machinery
-1,1451,1211,0751,014982.56
Construction In Progress
-32.3630.8435.730.2919.15